DR.PLINUS ZERO TROUBLE- gluconolactone, epigallocatechin gallatyl glucoside, madecassoside patch 
S Skin Co., Ltd.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

ACTIVE INGREDIENTS

Gluconolactone 2.14%
Epigallocatechin Gallatyl Glucoside 0.05%
Madecassoside 0.0013%(13ppm)

INACTIVE INGREDIENTS

Sodium Hyaluronate, Water, Butylene Glycol, Niacinamide, Ectoin, 1.2-Hexanediol, Centella Asiatica Extract

PURPOSE

Exfoliation
Sebum control
Calming

WARNINGS

1. Discontinue to use or consult with dermatologist if irritation, swelling or itching appears after applying the product
2. Avoid applying patches on the wounded, dermatitis, and inflamed skin parts
3. Safety and storage precautions
A) Keep out of children's reach
B) Keep away from direct sunlight
C) Use immediately after opening
D) Do not reuse the patch you have already attached once
E) For external use only

KEEP OUT OF REACH OF CHILDREN

Keep out of children's reach

Uses

■ Helps with exfoliation
■ Helps sebum control
■ Helps to soothe your skin

Directions

① Before using the patch, wash your face.
② Open the pouch and take the patches out from the clear case, and remove the protective films on patch
(* one by one. At this point, be careful not to touch the middle part of the patch.)
③ Adjust the patches on your face where you concern and press lightly at a right angle.
④ Attach the patch above at least 60 minutes.

Other Information

■ Do not store this product in an inappropriate place such as high or low temperatures or under direct sun light

QUESTIONS

■ https://www.drplinus.com/ +82.1811.8665

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of container

DR.PLINUS ZERO TROUBLE 
gluconolactone, epigallocatechin gallatyl glucoside, madecassoside patch
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72630-030
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GLUCONOLACTONE (UNII: WQ29KQ9POT) (GLUCONOLACTONE - UNII:WQ29KQ9POT) GLUCONOLACTONE0.029 mg  in 1.4 mg
EPIGALLOCATECHIN GALLATYL GLUCOSIDE (UNII: AR8RR3M6N9) (EPIGALLOCATECHIN GALLATYL GLUCOSIDE - UNII:AR8RR3M6N9) EPIGALLOCATECHIN GALLATYL GLUCOSIDE0.0007 mg  in 1.4 mg
Madecassoside (UNII: CQ2F5O6YIY) (Madecassoside - UNII:CQ2F5O6YIY) Madecassoside0.00001 mg  in 1.4 mg
Inactive Ingredients
Ingredient NameStrength
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
Water (UNII: 059QF0KO0R)  
Butylene Glycol (UNII: 3XUS85K0RA)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72630-030-029 in 1 CONTAINER05/01/2021
1NDC:72630-030-011.4 mg in 1 PATCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/01/2021
Labeler - S Skin Co., Ltd. (694879753)
Registrant - S Skin Co., Ltd. (694879753)
Establishment
NameAddressID/FEIBusiness Operations
BIOCOSONE CO.,LTD695729438manufacture(72630-030)

Revised: 10/2022
Document Id: e25994c4-c617-4eb9-999a-822d846670bb
Set id: ca117510-27f2-4344-8241-fdb564de1901
Version: 2
Effective Time: 20221018
 
S Skin Co., Ltd.